Relay Therapeutics
Shrikant Bhonsle serves as the Director of Drug Product Development at Relay Therapeutics since June 2022, bringing extensive experience in pharmaceutical formulation and development. Prior roles include Associate Director at Apotex Inc. and an Independent Consultant specializing in formulation development and technical operations. Shrikant has a strong background in managing external product development and tech transfers at Alvogen, as well as championing new technologies in R&D at Boehringer Ingelheim. With a proven track record of developing over 20 new chemical entity (NCE) formulations during tenure at Pharmaceutics International, Inc., Shrikant's expertise encompasses solid orals, sterile, and semi-solid dosage forms. Educational qualifications include a Master of Pharmacy in Biopharmaceutics from Govt. College of Pharmacy and a Bachelor of Pharmacy from Savitribai Phule Pune University.
This person is not in any teams
This person is not in any offices
Relay Therapeutics
2 followers
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology.